Found 0 matching trials
MesomiR 1: A Phase I Study of TargomiRs as 2nd or 3rd Line Treatment for Patients With Recurrent MPM and NSCLC PHASE1 The first testing of TargomiRs in the human setting: dose-finding studies i...
Show More Location
Concord Repatriation General Hospital
Learn More & Join Trial
PET/CT Based Radiomics for Lung Cancer (PERL) N/A The investigators investigate the utility of FDG PET/CT based radiomics in ...
Show More Location
Second Affiliated Hospital of Wenzhou Medical University
Learn More & Join Trial
Assessment of Multi-Modality Quantitative Imaging for Evaluation of Response of Metastatic Prostate Cancer to Therapy PHASE1 The study is an open label, non-randomized study designed to evaluate the d...
Show More Location
Johns Hopkins University
Learn More & Join Trial
Prostate Cancer Patients With Biochemical Recurrence N/A Evaluation of detection rate of 18F-Fluciclovine compared to current standa...
Show More Location
John Cochran VA Medical Center St. Louis
Learn More & Join Trial
Pre-operative Chemotherapy Plus Bevacizumab With Early Salvage Therapy Based on PET Assessment of Response in Patients With Locally Advanced But Resectable Gastric and GEJ Adenocarcinoma PHASE2 This study is being done to find out how effective a new treatment strategy...
Show More Location
Memorial Sloan Kettering Cancer Center
Learn More & Join Trial
Hip Impingement - Understanding Cartilage Damage NA Femoro-acetabular impingement (FAI) is a known cause of hip pain and possib...
Show More Location
The Ottawa Hospital
Learn More & Join Trial
Use of PET Imaging to Distinguish Malignant From Benign IPMN NA Intraductal papillary mucinous neoplasm (IPMN) is a cystic pancreatic lesio...
Show More Location
Columbia University Medical Center
Learn More & Join Trial
FDG-PET/CT Scans in Patients With Stage IIIB or Stage IV NSCLC Undergoing Chemotherapy NA RATIONALE: Diagnostic procedures, such as fludeoxyglucose F 18 (\^18FDG) po...
Show More Location
Jonsson Comprehensive Cancer Center at UCLA
Learn More & Join Trial
De-Escalated Adjuvant and Definitive Radiation Therapy Informed by DART 2.0 ctHPV-DNA PHASE2 This phase II trial examines the use of blood-based biomarkers is to help i...
Show More Location
Mayo Clinic in Arizona
Learn More & Join Trial
NaF Positron Emission Tomography/Computed Tomography (PET/CT)Imaging to Assess Treatment Responsiveness to TAK-700 in Patients With Castrate Resistant Prostate Cancer (CRPC) With Bone Metastasis PHASE2 The purpose of this study is to assess whether NaF PET/CT scans can be used...
Show More Location
University of Wisconsin Carbone Cancer Center
Learn More & Join Trial